Who has invested in Duality Biologics?

Lilly Asia Ventures, WuXi Biologics are named among the investors backing Duality Biologics.

Duality Biologics Funding: $120M Raised, Series B (2021)

Duality Biologics funding overview

Duality Biologics is based in Shanghai, China. Duality Biologics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Duality Biologics runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, WuXi Biologics. 2 distinct backers are named across the disclosed rounds.

Duality Biologics at a glance

Total raised: $120M
Latest round: Series B
Latest round date: May 2021
Headquarters: Shanghai, China
Notable investors: Lilly Asia Ventures, WuXi Biologics

Frequently asked about Duality Biologics funding

How much has Duality Biologics raised?: Duality Biologics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Duality Biologics?: Lilly Asia Ventures, WuXi Biologics are named among the investors backing Duality Biologics.
What was the latest Duality Biologics funding round?: The most recent disclosed round is a Series B, announced in May 2021.
Where is Duality Biologics based?: Duality Biologics is based in Shanghai, China.
When did Duality Biologics last raise?: The last disclosed Duality Biologics round closed in May 2021 at Series B.

Round data for Duality Biologics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

Duality Biologics Funding: $120M Raised, Series B (2021)

Duality Biologics funding overview

Duality Biologics at a glance

Frequently asked about Duality Biologics funding

Companies related to Duality Biologics (36)

Browse related funding lists (6)